Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BLIS Technologies Limited
No Price
Closing Price XNZE 28.04.2026:
0,02 NZD
28.04.2026 23:16
Current Prices from BLIS Technologies Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NZX
BLT.NZ
NZD
28.04.2026 23:16
0,02 NZD
0,00 NZD
Share Float & Liquidity
Free Float99,47 %
Shares Float1,27 B
Shares Outstanding1,28 B
Company Profile for BLIS Technologies Limited Share
BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company markets two strains of probiotic bacteria, which include BLIS K12, a probiotic supplement to support ear, nose, and throat health of young children, as well as for improving immunity and bad breath; BLIS M18, an oral probiotic to support teeth, gums, and dental health; and BLIS Q24, a probiotic supplement to balance and restore the skin microbiome, restoring the health, clarity, and radiance. It has operations in New Zealand, Asia Pacific, Europe, the Middle East, Africa, and North America. The company was incorporated in 2000 and is based in Dunedin, New Zealand.
